RxDoctor Payments Data

Leonard Buller, MD

Orthopaedic Surgery · Fishers, INNPI 1578805313

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $144,150 of the $166,259 with a category attached, or 86.7%. 19 manufacturers reported payments, led by Encore Medical, LP at 49.6% of the total. Reporting peaked in 2024 at $110,331 and has fallen 69.0% since, to $34,171 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$166,259in general payments, 2019–2025

Across 187 payments — averaging $889.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$82K
  • Smith+Nephew$53K
  • Osteoremedies, LLC$16K
  • Solventum Corporation$9K
  • KCI USA, Inc.$3K
  • Linkbio Corp$1K
  • plus $2K from 13 others
$137,201in research payments, 2019–2025

Across 13 payments — averaging $10,554 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Solventum Corporation$106K
  • Osteoremedies, LLC$24K
  • Applied Medical Resources Corporation$7K

What the payments were for

  • Consulting fees$144,15087%
  • Travel & lodging$12,6958%
  • Food & beverage$9,3856%
  • Gifts$290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$166,259 in reported general payments places this provider in the 90th percentile of 400 orthopaedic surgery providers in Indiana.

See all orthopaedic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$231,556
Medicare patients
341
Services billed
5,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin203$1,292
Celecoxib44$1,180
Cefadroxil13$313
Cyclobenzaprine Hcl12$289
Amoxicillin324$278
Omeprazole19$115
Clindamycin Hcl49$58
Cephalexin19$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fishers

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →